ACT Temozolomide
-
Generic name
temozolomide
-
Brand reference
Temodal®
-
Strength
20 mg
-
DIN
02395274
-
Therapeutic class
Antineoplastic Agent
-
Therapeutic area
Oncology
-
Package size
Bottle 5
-
Product code
17226-1005
-
UPC
830790004984
-
Generic name:
temozolomide
-
Brand reference:
Temodal®
-
Product code:
17226-1005
-
Strength
20 mg
-
DIN
02395274
-
UPC:
830790004984
-
Therapeutic class
Antineoplastic Agent
-
Therapeutic area:
Oncology
-
Package size:
Bottle 5
Composition
Active ingredient
temozolomide
Non-medicinal ingredients
colloidal silicon dioxide, lactose anhydrous, sodium starch glycolate, stearic acid and tartaric acid; capsule shells contain gelatin and, titanium dioxide and branded with black printing ink consisting of shellac, dehydrated alcohol, isopropyl alcohol, butyl alcohol, propylene glycol, strong ammonia solution, black iron oxide and potassium hydroxide, yellow iron oxide.
Product characteristics
-
Dosage form
capsule
-
Shape
-
Marking 1
TMZ
-
Marking 2
20
-
Colour
yellow
-
Secondary colour
white
-
Scored
-
Flavour
-
Gluten
currently not available
-
Latex
not applicable
Disclaimers
All information about raw materials and / or allergen information for Teva Canada’s products is obtained from our suppliers and/or third party affiliates and is based on their records.
Please be advised that the Medical Information department is not always notified of change in third party affiliates and / or change in suppliers of the excipients that may occur over time, and all information provided herein is based on our last current records.
"Latex" – refers to NATURAL RUBBER LATEX. We cannot guarantee that there is no latex in the outer packaging or that the medication or packaging haven’t come into contact with latex at any point during the manufacturing process, however this is very unlikely due to the strict GMP procedures that are in place in all of our manufacturing facilities. Employees in the manufacturing and / or packaging facilities may be wearing latex gloves
Product monograph/consumer information leaflet
View monograph
Notice
We are modifying our product names to align with our corporate name change. Accordingly, please expect product monographs to contain the “Novo-”, “ratio-”, “ACT”, "CO" prefix or the new “Teva” prefix. These prefixes may be used interchangeably on the website.
Should you have any questions about our product names or our corporate name change, please do not hesitate to contact us. Our Customer Care department can be reached at 1-800-268-4127 regarding your inquiry.